New York Times, June 13, 2024
The Supreme Court upheld access to a widely available abortion pill, rejecting a bid from a group of anti-abortion organizations and doctors to unravel the Food and Drug Administration’s approval of the pill.
In a unanimous decision, written by Justice Brett M. Kavanaugh, the court held that the plaintiffs lacked standing to challenge the F.D.A.’s actions.
Those who object to what a law allows others to do can always “seek greater regulatory or legislative restrictions on certain activities,” Justice Kavanaugh wrote. But the decision did not rule out the possibility that other plaintiffs — notably states — may be able to pursue challenges to the availability of mifepristone, a medication used in a majority of abortions in the country.